Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN113264839A details a high-ee route to levo-terbutaline using tert-butyl sulfinamide, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN118063421B reveals efficient Ottensinin synthesis. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN1642928A details novel routes for high-purity morpholine derivatives. Discover cost-effective enzymatic and chiral pool strategies for API manufacturing.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Patent CN102617503B details a novel Serine-based synthesis for high-purity S-3-Morpholinecarboxylic Acid, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.
Patent CN109609477B details a novel alpha-transaminase mutant enabling 100% conversion in L-glufosinate-ammonium synthesis, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel asymmetric synthesis of S-nicotine via tert-butyl sulfinamide induction. Offers high ee value, mild conditions, and scalable production for e-cigarette manufacturers.
Patent CN113475740B reveals a low-cost route for S-nicotine using methyl nicotinate. High yield, scalable process for e-cigarette manufacturers.
Novel maleimide-based route for high-purity calcium antagonist intermediates. Reduces cost and improves scalability for API manufacturing.
Patent CN108722480A reveals a novel Tröger's Base Schiff base catalyst offering high selectivity and mild conditions for cost reduction in fine chemical manufacturing.
Patent CN112142790B reveals advanced chiral PCP pincer complexes enabling high-efficiency asymmetric catalysis for reliable pharmaceutical intermediate supply chains.
Patent CN108046995A reveals a novel one-pot asymmetric synthesis for chiral intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Advanced synthesis of 5-biphenyl-4-ylmethylpyrrolidin-2-one via patent CN101631765B. Enhances purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN1118476C details a facile two-step synthesis of HIV protease inhibitors from mannose dilactone, offering cost reduction and scalability for pharmaceutical intermediates.
Novel synthetic method for Lacosamide intermediate ensuring 99.95% purity. Cost-effective and scalable solution for pharmaceutical manufacturing supply chains.
Patent CN107903276B details a catalytic asymmetric synthesis for cephalotaxine intermediates. This method offers high ee values and scalable production for pharmaceutical supply chains.
Novel patent CN115650868B details green L-carnitine synthesis technology. High yield, reduced waste, and scalable processes ensure supply chain reliability for global buyers.
Patent CN102363599A reveals a robust chiral resolution method for sitagliptin intermediates using D-di-p-toluoyl tartrate, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN102070497A details a novel 4-step Florfenicol synthesis. Discover cost reduction in veterinary drug manufacturing and high-purity intermediate supply strategies.